Metraipolis › archive › dc_8efbd5dfb2bb

Seizure adequacy and safety of remimazolam in electroconvulsive therapy for patients with psychiatric disorders: a double-blind randomized crossover trial — Europe PMC PMID:42174506

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42174506
DOI: 10.1186/s12888-[numero omesso]-x
License (as archived): solo-consultazione
Archived: 2026-11-01T10:12:32.896Z
SHA-256 of the archived text: 84e8212523064c0144a94964fbb91fd309a25544e55a90d8ca4664968af02398
Stable URL of this page: https://metraipolis.com/documento/dc_8efbd5dfb2bb

How to cite

Seizure adequacy and safety of remimazolam in electroconvulsive therapy for patients with psychiatric disorders: a double-blind randomized crossover trial — Europe PMC PMID:42174506 — Europe PMC (en), https://europepmc.org/article/MED/42174506 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8efbd5dfb2bb (Metraipolis archive dc_8efbd5dfb2bb, sha256 84e8212523064c0144a94964fbb91fd309a25544e55a90d8ca4664968af02398)

BibTeX

@misc{dc8efbd5dfb2bb,
  title = {Seizure adequacy and safety of remimazolam in electroconvulsive therapy for patients with psychiatric disorders: a double-blind randomized crossover trial — Europe PMC PMID:42174506},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42174506},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8efbd5dfb2bb; sha256 84e8212523064c0144a94964fbb91fd309a25544e55a90d8ca4664968af02398},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42174506. Agents can read the archived copy with the MCP tool read_document.